{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:25:11Z","timestamp":1791429911984,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302586"],"award-info":[{"award-number":["82302586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2024ZZTS0958"],"award-info":[{"award-number":["2024ZZTS0958"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.talanta.2025.128268","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:02:41Z","timestamp":1746532961000},"page":"128268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An automated magnetic-bead-assisted liquid chromatography-tandem mass spectrometry method for analyzing angiotensins, ALD, and 18-OH derivatives: Application of primary aldosteronism early screening and subtyping"],"prefix":"10.1016","volume":"295","author":[{"given":"Bingchu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nijiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.talanta.2025.128268_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the Kidney[J\/OL]","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.talanta.2025.128268_bib2","first-page":"801","article-title":"Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary Care[J\/OL]. Experimental and clinical endocrinology & diabetes: official journal","volume":"130","author":"Asbach","year":"2022","journal-title":"Ger. Soc. Endocrinol. German Diabet. Assoc."},{"issue":"5","key":"10.1016\/j.talanta.2025.128268_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, subtype classification, and outcomes of treatment of primary aldosteronism: a prospective study in China[J\/OL]","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.talanta.2025.128268_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study[J\/OL]","volume":"216","author":"Libianto","year":"2022","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.talanta.2025.128268_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101368","article-title":"Primary aldosteronism: treatment of the disease, and new therapeutic approaches[J\/OL]","volume":"34","author":"Funder","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.talanta.2025.128268_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary Aldosteronism[J\/OL]","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.talanta.2025.128268_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism[J\/OL]","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.talanta.2025.128268_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","article-title":"Primary aldosteronism: where are we now? Where to from Here?[J\/OL]","volume":"79","author":"Funder","year":"2022","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.talanta.2025.128268_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism \u2014 a multidimensional syndrome[J\/OL]","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.talanta.2025.128268_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice Guideline[J\/OL]","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.talanta.2025.128268_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[J\/OL]","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.talanta.2025.128268_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the diagnosis of primary aldosteronism and its Subtypes[J\/OL]","volume":"97","author":"Mulatero","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.talanta.2025.128268_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Peripheral plasma 18-Oxocortisol can discriminate unilateral adenoma from bilateral diseases in primary aldosteronism Patients[J\/OL]","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.talanta.2025.128268_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/jc.2014-3551","article-title":"Diagnostic value of ACTH stimulation test in determining the subtypes of primary Aldosteronism[J\/OL]","volume":"100","author":"Jiang","year":"2015","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.talanta.2025.128268_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry\u2013based adrenal and peripheral venous steroid profiling for subtyping primary Aldosteronism[J\/OL]","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.talanta.2025.128268_bib16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1515\/cclm-2023-0117","article-title":"Poor comparability of plasma renin activity measurement in determining patient samples: the status quo and recommendations for harmonization[J\/OL]","volume":"61","author":"Liu","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"11","key":"10.1016\/j.talanta.2025.128268_bib17","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1515\/cclm-2024-0373","article-title":"Insight into the status of plasma renin and aldosterone measurement: findings from 526 clinical laboratories in China[J\/OL]","volume":"62","author":"Zhou","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.talanta.2025.128268_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/cclm-2019-0706","article-title":"Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone[J\/OL]","volume":"58","author":"Yin","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.talanta.2025.128268_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1373\/clinchem.2016.255737","article-title":"Overestimation of aldosterone by immunoassay in renal Impairment[J\/OL]","volume":"62","author":"Lam","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2025.128268_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117325","article-title":"Reference intervals for LC-MS\/MS measurements of plasma renin activity, aldosterone, angiotensin II, and 24-hour urinary aldosterone in northern Chinese Han population[J\/OL]","volume":"543","author":"Yin","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2025.128268_bib21","article-title":"Simultaneous enrichment and ultrasensitive detection of angiotensin I, II, and III and aldosterone in human plasma based on magnetic covalent organic frameworks and LC-MS\/MS[J\/OL]","author":"Wang","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2025.128268_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122740","article-title":"A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma[J\/OL]","volume":"1179","author":"Chen","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2025.128268_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123030","article-title":"Liquid chromatography-tandem mass spectrometry (LC-MS\/MS) based assay for the simultaneous quantification of 18-hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in human plasma[J\/OL]","volume":"1188","author":"Chen","year":"2022","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.talanta.2025.128268_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1039\/D2AY01646J","article-title":"Development of a designed comparison method based on isotope dilution liquid chromatography\u2013tandem mass spectrometry for determining plasma renin activity and its clinical assessment of renin activity stability in plasma[J\/OL]","volume":"15","author":"Liu","year":"2023","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2025.128268_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464531","article-title":"Automated magnetic-bead-assisted sequential extraction technology for simultaneous detection of A\u03b21-42 and A\u03b21-40 in cerebrospinal fluid: an advance toward fully automated liquid chromatography-tandem mass spectrometry method[J\/OL]","volume":"1713","author":"Zou","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2025.128268_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117797","article-title":"Evolution of LC\u2013MS\/MS in clinical laboratoriesLC-MS\/MS[J\/OL]","volume":"555","author":"Yu","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2025.128268_bib27","doi-asserted-by":"crossref","first-page":"120058","DOI":"10.1016\/j.cca.2024.120058","article-title":"Application of magnetic bead-assisted liquid chromatography-tandem mass spectrometry method for analyzing serum bile acid profiles: advancing toward automated mass spectrometry","volume":"556","author":"Zhou","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.talanta.2025.128268_bib28","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1007\/s00216-022-03984-x","article-title":"An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry[J\/OL]","volume":"414","author":"Yu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"issue":"6","key":"10.1016\/j.talanta.2025.128268_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9703","article-title":"A biomarker panel of secondary hypertension is simultaneously quantified by coupling of magnetic solid-phase extraction and liquid chromatography-tandem mass spectrometry[J\/OL]","volume":"38","author":"Gao","year":"2024","journal-title":"Rapid Commun. Mass Spectrom.: RCM (Rapid Commun. Mass Spectrom.)"},{"issue":"2","key":"10.1016\/j.talanta.2025.128268_bib30","first-page":"802","article-title":"Novel magnetic-bead-assisted sequential extraction method for liquid chromatography-mass spectrometry (MS)\/MS of components with diverse properties: gastrin determination as a case Study[J\/OL]","volume":"95","author":"Ma","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2025.128268_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123943","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous quantitation of angiotensin (1\u20137), (1\u20138), (1\u20139) and (1\u201310) in human plasma[J\/OL]","volume":"1232","author":"Demeuse","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2025.128268_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jmsacl.2022.07.006","article-title":"Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability[J\/OL]","volume":"25","author":"Vogg","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"10.1016\/j.talanta.2025.128268_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124012","article-title":"A LC-MS\/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine[J\/OL]","volume":"1234","author":"Dong","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2025.128268_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114103","article-title":"Chloroform-based liquid-liquid extraction and LC\u2013MS\/MS quantification of endocannabinoids, cortisol and progesterone in human hair[J\/OL]","volume":"201","author":"Ney","year":"2021","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2025.128268_bib35","series-title":"Spectrometry Methods; Approved Guideline. CLSI Document C62-A[S]","year":"2014"},{"key":"10.1016\/j.talanta.2025.128268_bib36","series-title":"User Verification of Recision and Estimation of Bias; Approved Guideline","year":"2014"},{"issue":"3","key":"10.1016\/j.talanta.2025.128268_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/cclm-2020-0410","article-title":"Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods[J\/OL]","volume":"59","author":"Long","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.talanta.2025.128268_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115918","article-title":"Simultaneous quantification of 55 psychotropic drugs and metabolites in human plasma with a fast UPLC-MS\/MS method[J\/OL]","volume":"169","author":"Konecki","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.talanta.2025.128268_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465019","article-title":"Development and application of a sensitive liquid chromatography-tandem mass spectrometry method for the quantitative analysis of 11 free fatty acids in human serum using a derivatisation strategy[J\/OL]","volume":"1728","author":"Zeng","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"8","key":"10.1016\/j.talanta.2025.128268_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jchromb.2009.02.019","article-title":"Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma[J\/OL]","volume":"877","author":"Ionita Ileana","year":"2009","journal-title":"J. Chromatogr. B"},{"issue":"Pt 4","key":"10.1016\/j.talanta.2025.128268_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1258\/acb.2010.010027","article-title":"Quantification of unbound prednisolone, prednisone, cortisol and cortisone in human plasma by ultrafiltration and direct injection into liquid chromatrography tandem mass spectrometry[J\/OL]","volume":"47","author":"Ionita","year":"2010","journal-title":"Ann. Clin. Biochem."},{"issue":"5","key":"10.1016\/j.talanta.2025.128268_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/cclm-2023-0250","article-title":"A novel LC-MS\/MS-based assay for the simultaneous quantification of aldosterone-related steroids in human urine[J\/OL]","volume":"62","author":"Vogg","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"23","key":"10.1016\/j.talanta.2025.128268_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.70046","article-title":"Liquid chromatography column screening for the analysis of corrosion inhibitor molecules using derringer desirability Functions[J\/OL]","volume":"47","author":"Furno","year":"2024","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2025.128268_bib44","series-title":"ACQUITY Premier LC Technology Significantly Improves Sensitivity, Peak Shape and Recovery for Phosphorylated and Carboxylate Lipids[Z]","author":"Isaac","year":"2023"},{"issue":"29","key":"10.1016\/j.talanta.2025.128268_bib45","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1007\/s00216-024-05581-6","article-title":"Quantification of deoxythioguanosine in human DNA with LC-MS\/MS, a marker for thiopurine therapy optimisation[J\/OL]","volume":"416","author":"Carlsson","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2025.128268_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-3182-8_26","article-title":"Quantitation of plasma renin activity in plasma using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)[J\/OL]","volume":"1378","author":"Van Der Gugten","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"23","key":"10.1016\/j.talanta.2025.128268_bib47","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4155\/bio.12.268","article-title":"Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC-MS\/MS[J\/OL]","volume":"4","author":"Chappell","year":"2012","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.talanta.2025.128268_bib48","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41440-023-01347-2","article-title":"Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC\u2013MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol[J\/OL]","volume":"46","author":"Chang","year":"2023","journal-title":"Hypertens. Res."},{"issue":"8","key":"10.1016\/j.talanta.2025.128268_bib49","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2010-2785","article-title":"18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary Aldosteronism[J\/OL]","volume":"96","author":"Nakamura","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/j.talanta.2025.128268_bib50","doi-asserted-by":"crossref","first-page":"e3706","DOI":"10.1210\/clinem\/dgaa379","article-title":"Development and validation of prediction models for subtype diagnosis of patients with primary Aldosteronism[J\/OL]","volume":"105","author":"Burrello","year":"2020","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.talanta.2025.128268_bib51","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/HJH.0000000000002348","article-title":"Aldosterone-potassium ratio predicts primary aldosteronism subtype[J\/OL]","volume":"38","author":"Puar","year":"2020","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.talanta.2025.128268_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","article-title":"Serum 18-Hydroxycortisol in primary aldosteronism, hypertension, and Normotensives[J\/OL]","volume":"38","author":"Mosso","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.talanta.2025.128268_bib53","series-title":"Journal of Steroid Biochemistry and Molecular Biology","article-title":"18-Oxocortisol: a journey","author":"Gomez-Sanchez","year":"2023"},{"key":"10.1016\/j.talanta.2025.128268_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism[J\/OL]","volume":"5","author":"Rossi","year":"2020","journal-title":"Int. J. Cardiol. Hyperten."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914025007581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914025007581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:42:08Z","timestamp":1778474528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914025007581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0039914025007581"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2025.128268","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An automated magnetic-bead-assisted liquid chromatography-tandem mass spectrometry method for analyzing angiotensins, ALD, and 18-OH derivatives: Application of primary aldosteronism early screening and subtyping","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2025.128268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128268"}}